Beware of False “Cures” for Autism

What you need to know

Unapproved and Potentially Harmful Products

Autism Spectrum Disorder (ASD) affects about 1 in 68 children, and while early behavioral therapies can help improve symptoms, there is no cure for autism. Unfortunately, some companies promote unproven products that falsely claim to treat or even cure ASD — and some can be dangerous.

What the FDA Wants You to Know

The FDA has acted against companies marketing unapproved and potentially harmful products that claim to treat autism. These include:

  • Chelation Therapies (sprays, drops, baths): Meant to remove “toxins,” but can dangerously deplete essential minerals.
  • Hyperbaric Oxygen Chambers: Only approved for specific medical uses — not autism.
  • Detoxifying Clay Baths: Claim to “pull out toxins” through the skin — no evidence they help.
  • MMS (chlorine dioxide), raw camel milk, essential oils, and others: Heavily marketed, not scientifically proven, and can pose real health risks.

FDA-Approved Treatments Exist — But Only for Specific Symptoms

There are two FDA-approved medications to manage irritability associated with autism:

  • Risperidone (ages 5–16)
  • Aripiprazole (ages 6–17)

These medications help with specific symptoms — not autism itself — and should only be used under medical supervision.

Real Help for ASD

  • Early behavioral interventions can improve communication and daily living skills.
  • Treatment should be tailored to the individual’s needs.
  • Work with licensed healthcare professionals, not unregulated products.

Watch Out for These Red Flags

  • “Quick fixes” or “miracle cures”
  • Claims to treat a wide range of unrelated conditions
  • Personal stories with no scientific backing
  • Secret ingredients or “breakthrough science”

If it sounds too good to be true, it probably is.

If you have questions about therapies or treatments, talk to a doctor who specializes in autism. Trust science — not sales pitches.

Read more here

FDA – Do Not Use Non-piercing Devices to Measure Blood Glucose

FDA Safety Communication   On February 21, 2024 the U.S. Food and Drug Administration (FDA) issued a safety communication regarding the use of smartwatches or smart rings that claim to measure blood glucose levels without the need for skin piercing.   Its cautionary...

Medos International Recalls CEREBASE DA Guide Sheath 

Urgent Class I Recall Notice   Medos International Sàrl has issued an urgent recall for the Cerenovus CEREBASE DA Guide Sheath, a neurovascular catheter commonly used in procedures requiring precise navigation and access to blood vessels in the brain. The recall was...

Datex-Ohmeda Issues Field Correction for EVair Air Compressors 

Urgent Class I Recall Notice   Datex-Ohmeda Inc. has announced a field correction for its EVair and Jun-air compressors, optional ventilator accessories designed to provide an alternative source of airflow for patient support in clinical settings where wall air is...